Kexim successfully returned to the international dollar market yesterday (Wednesday) with a transaction that was increased and priced in line with expectations relative to its old rival KDB. Led by ABN AMRO, Barclays and UBS Warburg, a five-year Reg S deal was upsized from $500 million to $700 million and priced at 99.987% on a coupon of 4.25% to yield 4.253% or 127bp over Treasuries. Fees totaled 20bp.